In this report, we examine the requirement of cholesterol biosynthesis and its axonal transport for goldfish optic nerve regeneration. Cholesterol, labeled by intraocular injection of [3H]mevalonolactone. exhibited a delayed appearance in the optic tectum. Squalene and other minor components were labeled but not transported. Following optic nerve crush, the amount of labeled cholesterol transport was elevated, while retinal labeling was not altered relative to control fish. A requirement for cholesterol biosynthesis is inferred from the inhibition of neurite outgrowth in retinal explants caused by the cholesterol synthesis inhibitor, 20,25-diazacholesterol. The inhibition of growth could be overcome by addition of mevalonolactone, but not cholesterol, to the me- 
cholesterol synthesis and accumulation of labeled desmosterol and other lipids in fish retina and brain which persisted for 2 weeks, Diazacholesterol-treated fish showed no reduction in the amount of lipid-soluble radioactivity transported following intraocular injection of ['H]mevalonolactone. but there were alterations in the chromatographic pattern of the transported labeled lipids. In contrast to its effects on neurite outgrowth in vitro, diazacholesterol did not inhibit optic nerve regeneration in vivo, as measured both by arrival of labeled rapidly transported protein at the tectum and by time required for the return of visual function. Key Words: Diazacholesterol-Axonal transport-Neurite outgrowth-Goldfish retina. Heacock A. M. et al. Cholesterol synthesis and nerve regeneration. J . Neurochenz. 42, 987-993 ( 1984) .
During nerve regeneration, the cell body must synthesize and export the components necessary to rebuild the growing axon. The present study focuses on one of these components, cholesterol, a major membrane constituent that is thought to play a role in controlling membrane fluidity. Cholesterol, labeled from radioactive acetate or mevalonate, has been found to be transported rapidly in the chick (Rostas et a] ., 1979) and rat (Blaker et al., 1980) optic systems, while in the goldfish there is a report of a transient rapid peak of transport, followed by accumulation of radioactivity at a slow rate (Griffith and Larramendi, 1972) . Sterol depletion by 25-hydroxycholesterol treatment has been found to inhibit neurite outgrowth in neuroblastorna (Maltese et al., 1981) . In addition, 20,25-diazacholesterol (DAC), which blocks conversion of demosterol to cholesterol (Thompson et al., 1963) , has been reported to inhibit axonal transport of protein in frog sciatic nerve (Longo and Hammerschlag, 1980) . In this report, we investigate the various aspects of cholesterol metabolism during regeneration in the goldfish visual system, where in vivo studies of axonal transport and return of visual function, and in vitro studies of retinal explant neurite outgrowth can be carried out. Effects of DAC on nerve regrowth both in vitro and in vivo will be described.
EXPERIMENTAL PROCEDURES

Materials
Cholesterol and desmosterol were purchased from Serdary Laboratories. Squalene, mevalonolactone, and fatty acid-free bovine serum albumin were obtained from Sigma Chemical. 
Methods
Goldfish optic nerve crush was carried out as previously described (Landreth and Agranoff. 1976) . Fish were maintained at 20 -t I T , unless otherwise stated. Details of the procedure for explant culture of goldfish retina have been described elsewhere (Landreth and Agranoff. 1976; Heacock and Agranoff, 1977) . Briefly, retinas were removed from fish 10-15 days following optic nerve crush, cut into 500 pm squares with a Mcllwain tissue chopper, then placed onto polylysine-coated 35 mm tissue culture dishes with supplemented L-15 medium containing 10% fetal calf serum. The dishes, each containing 16 explants, were then stored in a humidified chamber maintained at 20 +. 1°C. For additions to the medium, aliquots of stock solutions of DAC (0.01 M) and/or mevalonolactone (200 mghl) were diluted with complete medium to the desired concentration, then filter-sterilized. The medium was prepared 24 h prior to use in order to allow time for conversion to mevalonic acid (MVA). The pH of the medium was then readjusted to pH 7.2 by addition of NaOH. Cholesterol-containing medium was prepared by dilution of a stock solution of cholesterol (10 mg/ml in ethanol) with either complete medium or L-15 containing 5 mg/ml of fatty acid-free bovine serum albumin in place of fetal calf serum. In experiments in which the latter medium was used, explants were grown initially for 2 days in complete medium, in order to allow attachment to the substratum, prior to replacement with albumin-containing medium. The extent of neurite outgrowth (nerve growth index) was estimated as previously described (Landreth and Agranoff, 1979) .
For in vivo labeling studies, groups of 6 saline-or DACtreated fish were injected in the right eye with 6-8 pCi [)H]MVA. After 24 h, the retinas were removed, frozen over dry ice, then stored at -20°C until analysis. The pooled retinas were homogenized in 1.0 ml of ice-cold water, then extracted by addition of 2.0 ml chloroform:methanol (1:l) (Schmitt and Elbein, 1979) . The resulting washed lipid extract containing the labeled isoprenoids was analyzed by thin layer chromatography on Brinkmann Silica gel G plates in hexane:ether:acetic acid (80:20: 1) or heptane:toluene (90: 10). The latter solvent was used for separation of squalene and cholesterol ester. Argentation TLC was carried out on plates which had been sprayed with a 40% aqueous solution of silver nitrate, then activated by heating at II0"C for at least 2 h. Following sample application, plates were run i n hexane:ether (10:90). Improved separation of cholesterol and desmosterol was obtained by rerunning the plates three more times in the same solvent. The positions of standard cholesterol and desmosterol were detected by charring lanes adjacent to those containing the labeled samples. Distribution of radioactivity was determined by scintillation counting of TLC scrapings or by fluorography of an Enhance (New England Nuclear)-sprayed plate exposed to XRP-5 film at -70°C. Prolonged exposures of approximately ten times longer than normal were required to compensate for the quenching effect of the silver nitrate.
For examination of the in vifro effects of DAC on cholesterol synthesis, groups of 6 retinas were incubated at 25°C for 4 to 36 h with 12.5 pCi of ['HIMVA in the medium of Dunlop et al. (1974) or in L-15 medium supplemented with 5 mM glucose, then processed as described above.
For studies of axonal transport of isoprenoids, fish were injected in the right eye with 5 FCi of ['HIMVA, and at 12 h to 48 days later, the right retina and both optic tecta were removed and analyzed for total lipid soluble radioactivity. Since the goldfish visual pathway is crossed, radioactivity in the ipsilateral or right optic tectum serves as a control for systemic labeling, and is subtracted from the value for the contralateral tectum to give the amount of transported radioactivity.
Axonal transport of protein was examined following intraocular injection of 2 pCi of ['Hlproline, by trichloroacetic acid precipitation of labeled tectal protein as previously described (Elam and Agranoff, 1971) . Retinal glycoprotein synthesis was determined similarly following a 90 min pulse of ['H]glucosamine (10 pCi). Protein concentration was determined by the method of Lowry et al.
Recovery of visual function was measured by shock avoidance responding (Kohsaka et al., 1982) . Goldfish were housed individually at 25°C throughout the experiment. The left eye was enucleated 7 days prior to crush of the right optic nerve. Fish were given 20 trial sessions in a shuttlebox 4 days and 3 days prior to crush. Each trial consisted of 15 s of light followed by 20 s of light plus repetitive shock and then darkness until onset of the next trial. Fish were retested twice weekly. The criterion for recovery of vision was 2 consecutive sessions in which crossing in the light exceeded crossing in the dark by at least 3 responses. Intraocular injections of 50 nmol DAC were found to have no effect on total incorporation of [3H]MVA into lipid-extractable material in the retina. However, argentation TLC (Fig. 2) revealed a striking inhibition of cholesterol synthesis and the accumulation of radioactivity in desmosterol and other unidentified compounds. Scintillation counting of TLC plate scrapings indicated a 97-99% inhibition of cholesterol labeling at even the lowest dose (0.2 nmol) of DAC tested. Intraperitoneal administration of DAC also resulted in substantial inhibition of retinal cholesterol labeling (Fig. 3) , an effect which persisted for up to 14 days following a single injection of DAC. Fish brain cholesterol synthesis was also reduced to I-3% of the control values.
RESULTS
Axonal
Effect of DAC on axonal transport of protein and sterols DAC has been reported to inhibit fast axonal transport of protein (Longo and Hammerschlag, 1980) . The inhibition of neurite outgrowth seen here might have been the result of such indirect effects of cholesterol synthesis inhibition. The potency of DAC in blocking cholesterol synthesis in vivo per- lipid extracted, and analyzed by argentation TLC.
In both saline and DAC-treated fish, 1,800-2,000 cpm of lipid-soluble radioactivity was transported per tectum. As previously found, in control fish all of the radioactivity comigrated with cholesterol. However, in the DAC-treated fish, there was no labeled cholesterol transported. Most of the radioactivity comigrated with compound C (as denoted in Fig. 2 ) , which may be similar to a substance reported to accumulate in DAC-treated chick muscle cultures (Rosenblum at al., 1979) .
Optic nerve regeneration
The prolonged action of DAC following intraperitoneal administration made it feasible to determine the effect of DAC on optic nerve regeneration in vivo. In these experiments, two assays were employed: a behavioral test for return of visual function, and measurement of the rapid transport of [3H]proline-labeled protein from the retina to the tectum. Fish were injected intraperitoneally at the time of optic nerve crush and weekly thereafter with either saline or 200 nmol of DAC. In contrast to the results seen on neurite outgrowth in retinal explants, DAC had no effect on the rate of optic nerve regeneration (Fig. 4) .
DISCUSSION
In a preliminary report, Griffith and Larramendi (1972) described a slow rate of cholesterol transport in the goldfish, preceded by a transient peak of radioactivity in the tectum at 12 h. While we have not been able to confirm the latter observation, the results presented here are consistent with a slow rate of cholesterol transport in the fish. Others, using [3H]cholesterol as a tracer, have also observed a slow rate of cholesterol transport in chick optic nerve (Rostas et al., 1979) and chick (McGregor et al., 1973) and mouse (Tang et al., 1974) sciatic nerve, although rapid rates of [)H]MVA or [3H]acetate-labeled cholesterol transport have been observed in the rat (Blaker et al., 1980) and chick (Rostas et al., 1979) optic systems. In the goldfish and other species, fast transport of phospholipids has also been reported (Miani, 1963; Currie et al., 1978) . While the first appearance of transported phospholipid in the axon is consistent with a rapid rate of transport, there is a slow rate of accumulation in axons and nerve terminals, which is thought to be accounted for by a delayed release of labeled phospholipid from the cell body. A similar delayed release of cholesterol has been described in the rat optic nerve (Blaker et al., 1980) . While such a phenomenon could contribute to the observations in the present study, the lack of any indication of rapid transport of labeled cholesterol remains unexplained. It may be that in the fish, rapidly transported cholesterol is incorporated efficiently into the proximal axonal membrane and subsequently slowly diffuses within the membrane to the nerve ending, such that determination of labeled cholesterol in proximal axon segments would be required to detect rapid cholesterol transport. During optic nerve regeneration, the amount of labeled cholesterol transported to the optic tectum was found to increase as much as fourfold, while no increase in incorporation of [3H]MVA into retinal cholesterol was detectable. However, such a response to axotomy of the relatively small population of ganglion cells within the retina cannot be ruled out. An enhanced labeling of transported cholesterol would also result from a decreased turnover of cholesterol in the axonal membrane or from an increased reutilization by tectal cells of cholesterol released from the axon. The enhanced transport of cholesterol A may reflect the requirement of the neuron to elaborate large amounts of new membrane and is in accord with reports of increased transport of phospholipids in regenerating rat sciatic (Dziegielewska et al.. 1980; Could et al., 1982) and rabbit hypoglossal nerves (Alberghina et al.. 1982) .
Further information on the link between cholesterol synthesis and nerve growth was provided by examination of the effects of DAC, an inhibitor of the AZ4-reductase step in cholesterol synthesis (Thompson et al., 1963) which, when administered to young rats, results in massive accumulation of desmosterol in the brain (Fumagalli et al., 1969; Suzuki et al., 1974; Ramsey, 1977) . In the present study, DAC was found to suppress neurite outgrowth from cultured retinal explants, a result in accord with the studies of Maltese and Volpe (1980) and Maltese et al. (1981) , who reported neuroblastoma outgrowth inhibition by 25-hydroxycholesterol. which could be reversed in serum-free cultures by low density lipoprotein (derived from fetal calf serum). This result contrasts with the failure of fetal calf serum to prevent, or exogenous cholesterol to reverse, the inhibition of neurite outgrowth from goldfish retinal explants caused by DAC. It may be that exogenous cholesterol is not taken up by the retinal ganglion cells, or that DAC has effects other than on cholesterol synthesis. The reversal of the growth inhibition by MVA suggests that de novo synthesis of cholesterol is required for neurite outgrowth in these cultures; however, elucidation of the mechanism of this effect is hindered by the known difficulty in demonstrating cholesterol synthesis in vitro (Jones et al., 1971) .
The possibility that the effects on nerve growth are due to changes in nonsterol metabolites of MVA deserves consideration, especially in light of recent descriptions of effects of MVA on cell shape or attachment to the culture substratum (Cohen et al., 1982; Schmidt et al., 1982) . One of these metabolites, dolichol, was found not to reverse the effects of DAC on neurite outgrowth. In addition, the incorporation of [3H]MVA in vivo into a minor radioactive band comigrating with dolichol was unaffected by DAC. It remains possible that nonsterol metabolites play a role in the effects of MVA on retinal explants.
Although the neurites exhibited no detectable morphological change with M DAC, the involvement of nonspecific membrane effects in the outgrowth inhibition cannot be ruled out. The degeneration of retinal explant neurites caused by M DAC may reflect its reported membrane disrupting effects (Rosenblum et al., 1979) .
Another possible mechanism for the neurite outgrowth block is inhibition of axonal transport of protein. In a study by Longo and Hammerschlag (1980) , DAC (5 x 10-411.1) was reported to suppress fast axonal transport in the frog sciatic nerve in vitro. However, in the goldfish visual system, under conditions in which cholesterol synthesis was completely blocked. no effects of DAC on either fast or slow axonal transport were seen. This discrepancy may be due to differences in the concentration of DAC used. since the frog dorsal root ganglion was exposed to concentrations of DAC at least 50-fold higher than those in the present study. It may be that the inhibition of axonal transport in the frog was due to nonspecific effects of high concentrations of DAC.
Support for the requirement of cholesterol synthesis for nerve growth was sought by examination of the effects of DAC on labeling of cholesterol from [3H]MVA in vivo. DAC proved to be a very potent inhibitor of cholesterol synthesis in vivo, at concentrations similar to those which inhibited neurite outgrowth. As would be predicted from earlier reports, DAC-treated fish accumulated radioactivity in desmosterol, but other unidentified labeled compounds also appeared (Fig. 2) . In DAC-treated fish, most of the axonally transported radioactivity was neither in cholesterol nor desmosterol but in an unknown compound, "C". These results suggest that DAC-inhibition of cholesterol synthesis may not be confined to the A24-reductase step.
The profound inhibition of cholesterol synthesis in vivo caused by DAC, taken together with the neurite outgrowth suppression in vitro, suggested that a similar effect on optic nerve regeneration would be seen in vivo. However, neither biochemical nor behavioral measures of regeneration revealed inhibitory effects of DAC. We conclude that either cholesterol is not needed for nerve growth, that other sterols may subsitute for cholesterol in the growing nerve, or that sources of pre-existing cholesterol can compensate for the deficit in newlysynthesized cholesterol. Such sources of cholesterol in the whole animal are not available to the retinal explant in vitro. The tissue culture environment may also place more stringent requirements on the membrane properties of the growing axon, e.g., the need to attach to and grow along a plastic surface. Whatever the reason for the differing outcomes of the in vivo and in vitro experiments, these observations underscore that caution be exercised in generalizing from tissue culture studies to the whole animal.
